Skip to main content
. 2016 Dec 21;22(2):118–125. doi: 10.1016/j.rpor.2016.10.001

Fig. 1.

Fig. 1

72-Year old female with liver metastases from NSCLC. (a) Diagnostic abdomen MRI and dose in color wash in planning treatment using MRI fusion. Dose: integrated boost (12 Gy in the periphery and 15 Gy in the center of the lesion) × 3 fractions. (b) PEC CT at diagnosis and consequently follow-up at 3 months, and 5 years and 11 months after SBRT completion, respectively, showing complete response.